140
Participants
Start Date
October 3, 2008
Primary Completion Date
May 17, 2016
Study Completion Date
May 31, 2026
cranial radiotherapy
40 Gy
intensive chemotherapy and hematopoietic stem cell rescue
intensive chemotherapy and hematopoietic stem cell rescue
MTX based chemotherapy
R-MBVP 2 cycles day1 and day28 followed by R-Aracytine 2 cycles days58\&59 and days79\&80
CHU de la Timone, Marseille
Institut Bergonié, Bordeaux
Hôpital Pontchaillou, Rennes
CHU Michalon, Grenoble
CHU Nancy - Hôpital Neurologique, Vandœuvre-lès-Nancy
CHG Saint Jean, Perpignan
GH Pitié-Salpétrière, Paris
Cancérologie Hôpital Sud, Amiens
CHU Hôpital Bernard, Poitiers
CHU de Limoges, Limoges
Centre René Huguenin, Saint-Cloud
CHR Argenteuil, Argenteuil
Chu D'Angers, Angers
CHU de Besancon, Besançon
CHU Hôtel Dieu, Clermont-Ferrand
Centre Hospitalier Lens, Lens
Hôtel Dieu Nantes, Nantes
Centre Antoine Lacassagne, Nice
CHU de Nimes, Nîmes
Chu Reims, Reims
Institut de Cancérologie, Saint-Priest-en-Jarez
CH de Saint-Quentin, Saint-Quentin
Hôpital Bretonneau, Tours
Collaborators (2)
Ministry of Health, France
OTHER_GOV
Hoffmann-La Roche
INDUSTRY
Amgen
INDUSTRY
Pierre Fabre Laboratories
INDUSTRY
Institut Curie
OTHER